Published: August 01, 2011
New High-speed 3-D Imaging System Holds Potential for Improved Cancer Screening
WASHINGTON - (BUSINESS WIRE) - Researchers at the Massachusetts Institute of Technology (MIT) have
developed a new imaging system that enables high-speed,
three-dimensional (3-D) imaging of microscopic pre-cancerous changes in
the esophagus or colon. The new system, described in the Optical
Society's (OSA)
open access journal Biomedical
Optics Express, is based on an emerging technology called
optical coherence tomography (OCT), which offers a way to see below the
surface with 3-D, microscopic detail in ways that traditional screening
methods can't.
Endoscopy is the method of choice for cancer screening of the colon or
esophagus. In the procedure, a tiny camera attached to a long thin tube
is snaked into the colon or down the throat, giving doctors a relatively
non-invasive way to look for abnormalities. But standard endoscopy can
only examine the surface of tissues, and thus may miss important changes
occurring inside tissue that indicate cancer development.
OCT, which can examine tissue below the surface, is analogous to
medical ultrasound imaging except that it uses light instead of sound
waves to visualize structures in the body in real time, and with far
higher resolution; OCT can visualize structures just a few millionths of
a meter in size. Over the past two decades, OCT has become commonplace
in ophthalmology, where it is being used to generate images of the
retina and to help diagnose and monitor diseases like glaucoma, and has
emerging applications in cardiology, where it's used to examine unstable
plaques in blood vessels that can trigger heart attacks.
The new endoscopic OCT imaging system reported by OCT pioneer James G.
Fujimoto of MIT and his colleagues, works at record speeds, capturing
data at a rate of 980 frames (equivalent to 480,000 axial scans) per
second-nearly 10 times faster than previous devicesâwhile imaging
microscopic features less than 8 millionths of a meter in size.
At such high speeds and super-fine resolution, the novel system promises
to enable 3-D microscopic imaging of pre-cancerous changes in the
esophagus or colon and the guidance of endoscopic therapies. Esophageal
and colon cancer are diagnosed in more than 1.5 million people worldwide
each year, according to the American Cancer Society.
"Ultrahigh-speed imaging is important because it enables the acquisition
of large three-dimensional volumetric data sets with micron-scale
resolution," says Fujimoto, a professor of electrical engineering and
computer science and senior author of the paper.
"This new system represents a significant advance in real-time, 3-D
endoscopic OCT imaging in that it offers the highest volumetric imaging
speed in an endoscopic setting, while maintaining a small probe size and
a low, safe drive voltage," says Xingde Li, associate professor at the
Whitaker Biomedical Engineering Institute and Department of Biomedical
Engineering at Johns Hopkins University, who is not affiliated with the
research team.
In OCT imaging, microscopic-scale structural and pathological features
are examined by directing a beam of light on a tissue and measuring the
magnitude and echo time-delay of backscattered light. Because the amount
of light that can be recaptured and analyzed decreases quickly with
depth in tissue due to scattering, the technique can generally only be
used to visualize sub-surface features to a depth of 1 to 2 millimeters.
"However these depths are comparable to those sampled by pinch biopsies
and unlike biopsy, information is available in real time," Fujimoto
says. By using miniature fiber optic scanning catheters or probes,
either on their own or in combination with standard endoscopes,
colonoscopes, or laparoscopes, OCT imaging can be performed inside the
body.
In collaboration with clinicians at the VA Boston Healthcare System and
Harvard Medical School, the team is investigating endoscopic OCT as a
method for guiding excisional biopsy-the removal of tissue for
histological examination-to reduce false negative rates and improve
diagnostic sensitivity.
"Excisional biopsy is one of the gold standards for the diagnosis of
cancer, but is a sampling procedure. If the biopsy is taken in a normal
region of tissue and misses the cancer, the biopsy result is negative
although the patient still has cancer," notes Fujimoto, whose team is
one of a number of research groups-including at Johns Hopkins
University; the University of California, Irvine; Case Western
University; and Massachusetts General Hospital-that are actively
pursuing the development of smaller, faster endoscopic OCT systems.
Endoscopic OCT requires miniature optical catheters or probes-just a few
millimeters in diameter-that can scan an optical beam in two dimensions
to generate high-resolution 3-D data sets. Scanning the beam in
one transverse direction generates an image in a cross-sectional plane,
whereas scanning the beam in two directions generates a stack of
cross-sectional images-that is, a 3-D (or volumetric), image.
"This device development is one of the major technical challenges in
endoscopic OCT because probes must be small enough so that they can be
introduced into the body, but still be able to scan an optical beam at
high speeds," Fujimoto says. "Increasing imaging speeds has also been an
important research objective because high-resolution volumetric imaging
requires very large amounts of data in order to cover appreciable
regions of tissue, so rapid image acquisition rates are a powerful
advantage."
The optical catheter developed by the MIT researchers and their
collaborators uses a piezoelectric transducer, a miniature device that
bends in response to electrical current, allowing a laser-light emitting
optical fiber to be rapidly scanned over the area to be imaged.
So far, the device-which must be further reduced in size, Fujimoto
notes, before it can be deployed with the standard endoscopes now
used-has only been used in animal models and in samples of human colons
that had been removed during surgical procedures; further development
and testing of the technology is needed before it can be tested in human
patients. "The ultimate clinical utility of new devices must be
established by large clinical studies, which assess the ability of the
technology to improve diagnoses or therapy," he says. "This is a much
more complex and lengthy task than the initial development of the
technology itself."
The paper, titled "Piezoelectric
Transducer Based Miniature Catheter for Ultrahigh Speed Endoscopic
Optical Coherence Tomography," was also coauthored by Tsung-Han
Tsai, Benjamin Potsaid, Martin F. Krauss, Chao Zhou, Yuankai K. Tao, and
Joachim Hornegger, and appears in the Aug. 1 issue of Biomedical
Optics Express (vol. 2, issue 8, pp. 2438-2448).
EDITOR'S NOTE: A high-resolution image of a 3-D OCT volumetric data set
from an excised human colon specimen is available upon request. Contact astark@osa.org.
About Biomedical Optics Express
Biomedical Optics Express is OSA's principal outlet for serving
the biomedical optics community with rapid, open-access, peer-reviewed
papers related to optics, photonics and imaging in the life sciences.
The journal scope encompasses theoretical modeling and simulations,
technology development, and biomedical studies and clinical
applications. It is published by the Optical Society and edited by
Joseph A. Izatt of Duke University. Biomedical Optics Express is
an open-access journal and is available at no cost to readers online at www.OpticsInfoBase.org/BOE.
About OSA
Uniting more than 106,000 professionals from 134 countries, the Optical
Society (OSA) brings together the global optics community through its
programs and initiatives. Since 1916 OSA has worked to advance the
common interests of the field, providing educational resources to the
scientists, engineers and business leaders who work in the field by
promoting the science of light and the advanced technologies made
possible by optics and photonics. OSA publications, events, technical
groups and programs foster optics knowledge and scientific collaboration
among all those with an interest in optics and photonics. For more
information, visit www.osa.org.

The Optical Society
Angela Stark, 202-416-1443
astark@osa.org
or
American
Institute of Physics
Charles Blue, 301-209-3091
cblue@aip.org
Copyright © 2012, Business Wire, Inc., All rights reserved.
Copyright © 2012, NewsBlaze,
Daily News